Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function

Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function

The lack of tumour-specific antigens and control over T-cell activity limits the development of CAR-T cell therapies for solid tumours. Here the authors present an avidity-controlled CAR platform with inducible logic control functions.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Benjamin Salzer, Christina M. Schueller, Charlotte U. Zajc, Timo Peters, Michael A. Schoeber, Boris Kovacic, Michelle C. Buri, Elisabeth Lobner, Omer Dushek, Johannes B. Huppa, Christian Obinger, Eva M. Putz, Wolfgang Holter, Michael W. Traxlmayr, Manfred Lehner
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
Science
Q
Accès en ligne:https://doaj.org/article/8783689044924d8ba5fdd958f3eeabd4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/8783689044924d8ba5fdd958f3eeabd4

Documents similaires